Healthcare - Biotechnology - NASDAQ - GB
$ 0.682
-38.6 %
$ 3.53 M
Market Cap
-1.1
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
1473.46%
EBIT
Estimate
--146.77%
Net Income
Estimate
163.85%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Aptorum Group Limited
APM has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart APM
EBIT FORECAST
EBIT Forecast Chart APM
NET INCOME FORECAST
Net Income Chart APM